Frequent promoter methylation of CDH1 in non-neoplastic mucosa of sporadic diffuse gastric cancer

Anticancer Research

Volumn 33, Issue 9, 2013, Pages 3765-3774

  Lee, Kyung Hwa ^a   Hwang, David ^b   Young Kang, Ki ^b   Lee, Soong ^b   Kim, Dong Yi ^a   Joo, Young Eun ^a   Lee, Jae Hyuk ^a  

^a Chonnam National University Medical School   (South Korea)

^b Seonam University   (South Korea)

Author keywords

Diffuse gastric cancer; Human CDH1 protein; Methylation; Methylation specific polymerase chain reaction; Pyrosequencing; Stomach neoplasm

Indexed keywords

UVOMORULIN;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; CPG ISLAND; DIFFUSE GASTRIC CANCER; DISTANT METASTASIS; DNA METHYLATION; FEMALE; GENE SILENCING; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PYROSEQUENCING; QUANTITATIVE ANALYSIS; STATISTICAL SIGNIFICANCE; STOMACH CANCER; STOMACH MUCOSA; TUMOR VOLUME;

DIFFUSE GASTRIC CANCER; HUMAN CDH1 PROTEIN; METHYLATION; METHYLATION-SPECIFIC POLYMERASE CHAIN REACTION; PYROSEQUENCING; STOMACH NEOPLASM;

BASE SEQUENCE; CADHERINS; DNA METHYLATION; DNA PRIMERS; FEMALE; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; STOMACH NEOPLASMS;

EID: 84885014198     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893-2917, 2010.
2. Khushalani N: Cancer of the esophagus and stomach. Mayo Clin Proc 83: 712-722, 2008.
3. Lauwers GY, Carneiro F, Graham DY, Curado MP, Franceschi S, Tatematsu M and Hattori T: Gastric carcinoma. In: WHO Classification of Tumours of the Digestive System, Bosman FT, Carneiro F, Hruban RH, Theise ND (eds.). Lyon: International Agency for Research on Cancer, pp. 48-58, 2010.
4. Oliveira C, Sousa S, Pinheiro H, Karam R, Bordeira-Carrico R, Senz J, Kaurah P, Carvalho J, Pereira R, Gusmao L, Wen X, Cipriano MA, Yokota J, Carneiro F, Huntsman D and Seruca R: Quantification of epigenetic and genetic second hits in CDH1 during hereditary diffuse gastric cancer syndrome progression. Gastroenterology 136: 2137-2148, 2009.
5. Becker KF, Atkinson MJ, Reich U, Becker I, Nekarda H, Siewert JR and Hofler H: E-Cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res 54: 3845-3852, 1994.
6. Guilford P, Hopkins J, Harraway J, McLeod M, McLeod N, Harawira P, Taite H, Scoular R, Miller A and Reeve AE: ECadherin germline mutations in familial gastric cancer. Nature 392: 402-405, 1998.
7. Oliveira C, Bordin MC, Grehan N, Huntsman D, Suriano G, Machado JC, Kiviluoto T, Aaltonen L, Jackson CE, Seruca R and Caldas C: Screening E-Cadherin in gastric cancer families reveals germline mutations only in hereditary diffuse gastric cancer kindred. Hum Mutat 19: 510-517, 2002.
8. Grady WM, Willis J, Guilford PJ, Dunbier AK, Toro TT, Lynch H, Wiesner G, Ferguson K, Eng C, Park JG, Kim SJ and Markowitz S: Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer. Nat Genet 26: 16-17, 2000.
9. Oliveira C, de Bruin J, Nabais S, Ligtenberg M, Moutinho C, Nagengast FM, Seruca R, van Krieken H and Carneiro F: Intragenic deletion of CDH1 as the inactivating mechanism of the wild-type allele in an HDGC tumour. Oncogene 23: 2236-2240, 2004.
10. Liu YC, Shen CY, Wu HS, Hsieh TY, Chan DC, Chen CJ, Yu JC, Yu CP, Harn HJ, Chen PJ, Hsieh CB, Chen TW and Hsu HM: Mechanisms inactivating the gene for E-Cadherin in sporadic gastric carcinomas. World J Gastroenterol 12: 2168-2173, 2006.
11. Machado JC, Oliveira C, Carvalho R, Soares P, Berx G, Caldas C, Seruca R, Carneiro F and Sobrinho-Simoes M: E-Cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma. Oncogene 20: 1525-1528, 2001.
12. Stomach. In: AJCC Cancer Staging Manual. Edge SB, Byrd DR, Compton CC, Fritz AG Greene FL and Trotti A (eds.). Springer Press, pp. 117-126, 2009.
13. Moskaluk CA and Kern SE: Microdissection and polymerase chain reaction amplification of genomic DNA from histological tissue sections. Am J Pathol 150: 1547-1552, 1997.
14. Herman JG, Graff JR, Myohanen S, Nelkin BD and Baylin SB: Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93: 9821-9826, 1996.
15. Li Y, Chen CQ, He YL, Cai SR, Yang DJ, He WL, Xu JB and Zan WH: Abnormal expression of E-Cadherin in tumor cells is associated with poor prognosis of gastric carcinoma. J Surg Oncol 106: 304-10, 2012.
16. Grunwald GB: The structural and functional analysis of Cadherin calcium-dependent cell adhesion molecules. Curr Opin Cell Biol 5: 797-805, 1993.
17. Takeichi M: Cadherins: A molecular family important in selective cell-cell adhesion. Annu Rev Biochem 59: 237-252, 1990.
18. Chan AO, Lam SK, Wong BC, Wong WM, Yuen MF, Yeung YH, Hui WM, Rashid A and Kwong YL: Promoter methylation of ECadherin gene in gastric mucosa associated with Helicobacter pylori infection and in gastric cancer. Gut 52: 502-506, 2003.
19. Wijnhoven BP, Dinjens WN and Pignatelli M: E-Cadherin-catenin cell-cell adhesion complex and human cancer. Br J Surg 87: 992-1005, 2000.
20. Gayther SA, Gorringe KL, Ramus SJ, Huntsman D, Roviello F, Grehan N, Machado JC, Pinto E, Seruca R, Halling K, MacLeod P, Powell SM, Jackson CE, Ponder BA and Caldas C: Identification of germ-line E-Cadherin mutations in gastric cancer families of European origin. Cancer Res 58: 4086-4089, 1998.
21. Blok P, Craanen ME, Dekker W and Tytgat GN: Loss of ECadherin expression in early gastric cancer. Histopathology 34: 410-415, 1999.
22. Chan AO, Wong BC, Lan HY, Loke SL, Chan WK, Hui WM, Yuen YH, Ng I, Hou L, Wong WM, Yuen MF, Luk JM and Lam SK: Deregulation of E-Cadherin-catenin complex in precancerous lesions of gastric adenocarcinoma. J Gastroenterol Hepatol 18: 534-539, 2003.
23. Chan AO, Huang C, Hui WM, Cho CH, Yuen MF, Lam SK, Rashid A and Wong BC: Stability of E-Cadherin methylation status in gastric mucosa associated with histology changes. Aliment Pharmacol Ther 24: 831-836, 2006.
24. An Q, Liu Y, Gao Y, Huang J, Fong X, Li L, Zhang D and Cheng S: Detection of p16 hypermethylation in circulating plasma DNA of non-small cell lung cancer patients. Cancer Lett 188: 109-114, 2002.
25. Shaw RJ, Liloglou T, Rogers SN, Brown JS, Vaughan ED, Lowe D, Field JK and Risk JM: Promoter methylation of P16, RARβ, ECadherin, cyclin A1 and cytoglobin in oral cancer: Quantitative evaluation using pyrosequencing. Br J Cancer 94: 561-568, 2006.
26. Tost J, El abdalaoui H and Gut IG: Serial pyrosequencing for quantitative DNA methylation analysis. Biotechniques 40: 721-722, 724, 726, 2006.
27. Laird PW: The power and the promise of DNA methylation markers. Nat Rev Cancer 3: 253-266, 2003.
28. Uhlmann K, Brinckmann A, Toliat MR, Ritter H and Nurnberg P: Evaluation of a potential epigenetic biomarker by quantitative methyl-single nucleotide polymorphism analysis. Electrophoresis 23: 4072-4079, 2002.
29. Colella S, Shen L, Baggerly KA, Issa JP and Krahe R: Sensitive and quantitative universal Pyrosequencing methylation analysis of CpG sites. Biotechniques 35: 146-150, 2003.
30. Barber M, Murrell A, Ito Y, Maia AT, Hyland S, Oliveira C, Save V, Carneiro F, Paterson AL, Grehan N, Dwerryhouse S, Lao-Sirieix P, Caldas C and Fitzgerald RC: Mechanisms and sequelae of ECadherin silencing in hereditary diffuse gastric cancer. J Pathol 216: 295-306, 2008.
31. Dong HM, Liu G, Hou YF, Wu J, Lu JS, Luo JM, Shen ZZ and Shao ZM: Dominant-negative E-Cadherin inhibits the invasiveness of inflammatory breast cancer cells in vitro. J Cancer Res Clin Oncol 133: 83-92, 2007.
32. Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y and Goodall GJ: The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 10: 593-601, 2008.
33. Park SM, Gaur AB, Lengyel E and Peter ME: The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-Cadherin repressors ZEB1 and ZEB2. Genes Dev 22: 894-907, 2008.
34. Berx G, Becker KF, Hofler H and van Roy F: Mutations of the human E-Cadherin (CDH1) gene. Hum Mutat 12: 226-237, 1998.
35. Tamura G, Yin J, Wang S, Fleisher AS, Zou T, Abraham JM, Kong D, Smolinski KN, Wilson KT, James SP, Silverberg SG, Nishizuka S, Terashima M, Motoyama T and Meltzer SJ: E-Cadherin gene promoter hypermethylation in primary human gastric carcinomas. J Natl Cancer Inst 92: 569-573, 2000.
36. Muta H, Noguchi M, Kanai Y, Ochiai A, Nawata H and Hirohashi S: E-Cadherin gene mutations in signet ring cell carcinoma of the stomach. Jpn J Cancer Res 87: 843-848, 1996.
37. Tamura G: Alterations of tumor suppressor and tumor-related genes in the development and progression of gastric cancer. World J Gastroenterol 12: 192-198, 2006.
38. Ushijima T and Sasako M: Focus on gastric cancer. Cancer cell 5: 121-125, 2004.
39. Yamamoto E, Suzuki H, Takamaru H, Yamamoto H, Toyota M and Shinomura Y: Role of DNA methylation in the development of diffuse-type gastric cancer. Digestion 83: 241-249, 2011.